MCM
PASG icon

MAI Capital Management’s Passage Bio PASG Stock Holding History

MAI Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$1.61K – 4453
2025
Q3 		$1.61K Buy
+200
New +$1.39K ﹤0.01% 3359
2025
Q2 		– Sell
-200
Closed -$1.41K – 4022
2025
Q1 		$1.41K Hold
200
– – ﹤0.01% 3043
2024
Q4 		$2.27K Buy
+200
New +$2.6K ﹤0.01% 3003

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MAI Capital Management's PASG Position: Q4 2025 in Review

MAI Capital Management sold out of Passage Bio (PASG) in Q4 2025, closing a stake of 200 shares — an estimated $1.61K sold.

MAI Capital Management first reported a position in PASG in Q4 2024 and held it in 3 quarters. The position peaked at $2.27K in Q4 2024. 30 funds tracked by Wall St. Rank hold PASG as of Q4 2025.

  • MAI Capital Management reported no remaining Passage Bio position as of Q4 2025 after selling out during the quarter.
  • MAI Capital Management sold 200 Passage Bio shares in Q4 2025, an estimated $1.61K.
  • MAI Capital Management first reported a position in Passage Bio in Q4 2024 and held it in 3 quarters.
  • MAI Capital Management's Passage Bio position peaked at $2.27K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q4 2025.

Based on MAI Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.